Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's). - Wikidata - wikimedia - TriplyDB

Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's).

Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's).

http://www.wikidata.org/entity/Q35649141

about

Interventions for renal vasculitis in adults Exploration, Development, and Validation of Patient-reported Outcomes in Antineutrophil Cytoplasmic Antibody-associated Vasculitis Using the OMERACT Process Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12 Patient-Reported Outcomes in Glomerular Disease.The informational needs of patients with ANCA-associated vasculitis-development of an informational needs questionnaire Patient-reported outcomes in ANCA-associated vasculitis. A comparison between Birmingham Vasculitis Activity Score and routine assessment of patient index data 3.The Rare Diseases Clinical Research Network's organization and approach to observational research and health outcomes research Current status of outcome measure development in vasculitis.The impact of current health-related quality of life on future health outlook in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).Trends in Long-Term Outcomes Among Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Renal Disease Clinical course and outcomes of childhood-onset granulomatosis with polyangiitis.Key advances in the clinical approach to ANCA-associated vasculitis.Pain in autoimmune disorders.OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.The characterisation and determinants of quality of life in ANCA associated vasculitis.Patient and physician perspectives on the impact of health-related quality of life in Mexican patients with ANCA-associated vasculitis.Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure.Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis.[S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis].Successful treatment with tocilizumab in a case of Cogan's syndrome complicated with aortitis.

P2860

Q24187038-E504E8EA-1394-4C63-AE48-D9CB5ED5CE33 Q26795465-F03C4A4B-43C5-4A88-89F2-5950F9579D1D Q28081372-5A96445C-9D35-4AF6-94D8-CBECB3BCD744 Q30249861-6E7BF9A3-53DA-4591-B3FF-C6A3A8C47E63 Q30584285-BC1A6E00-FFD5-4D20-82CB-949F0E5FA9A5 Q30919439-15ABF915-E864-4C85-8EC1-136009901D82 Q34011952-376A5616-E558-4F5E-89C8-8FBC38377CED Q35865798-AC238FAB-9C51-4648-81DC-B8559BBE99EC Q36927595-875457DE-5D53-4945-826D-2C3A5ECD2709 Q37037298-214EDBB8-EE00-45F7-8341-843BE2D12E69 Q37739043-14737A28-383A-45A9-99A6-06E566573AC9 Q38224803-25DC8505-1278-42F8-8A32-B02434C6CD65 Q38905689-4E04E515-AAFA-4B26-A9C1-405858645720 Q40060881-F2BE9653-B012-4FF6-9F1D-CFFB2EE4D245 Q43524663-27FA01DB-000A-42FB-B30B-C1B1C6E4742B Q47299381-739921A7-924B-477E-95D3-AB0001319087 Q47552107-B59683A5-3E84-4C9C-8C7B-EDBEDBA32089 Q47619266-8C9E1A0B-F8A4-41CD-B73A-8C2771D63A0B Q50076914-8813C0A5-8C71-41AB-B9AC-B7970837C695 Q50430122-19CE7BA3-B483-4F87-8D0D-66EFA325FD9C

P2860

Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's).

http://www.wikidata.org/entity/Q35649141

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Assessment of health-related q ...... with polyangiitis (Wegener's).

@ast

Assessment of health-related q ...... with polyangiitis (Wegener's).

@en

type

label

Assessment of health-related q ...... with polyangiitis (Wegener's).

@ast

Assessment of health-related q ...... with polyangiitis (Wegener's).

@en

prefLabel

Assessment of health-related q ...... with polyangiitis (Wegener's).

@ast

Assessment of health-related q ...... with polyangiitis (Wegener's).

@en

P1433

Q35649141-79756A9A-5C07-4E17-9F8B-441554D247A2

P1476

Q35649141-E55CB426-5D58-496B-BA09-17D3845E5F68

P2093

Q35649141-0084DBBB-1C8B-4E4D-A37F-BF85B1363C91

Q35649141-0C6DB695-CA42-4855-82FA-3478B49B3AE9

Q35649141-188C1DBF-E156-4A27-93D6-9E7592990F79

Q35649141-1961E3E7-CACC-4C35-BA9B-479D1AEB5AE6

Q35649141-232969DC-983E-41C7-B540-0A32BDBE86E4

Q35649141-2F54F033-1884-4238-BD85-45F07AC453EA

Q35649141-3C401ADE-6D82-433E-BCF8-7C476E617E7D

Q35649141-40BD1401-2C28-4F87-9D8A-DE19056AC9A0

Q35649141-504454DD-BBED-4ED9-B608-A257F7666BCE

Q35649141-588B60DD-36DA-41DB-A219-E4E2CC0EE61D

P2860

Q35649141-037999BD-06BB-438A-984D-8372A50A570E

Q35649141-099586C9-9855-46FB-A812-1D3C81D6E5CC

Q35649141-0E3D90C7-6457-46E8-8728-DAA6C350EACB

Q35649141-0E45410A-DA56-43BB-9812-693C5123846A

Q35649141-15D4FFB5-CAF2-48C7-AEB2-B30A135131E1

Q35649141-258B37E3-C00E-4428-AC0B-E36364057828

Q35649141-3ABAB9FC-6C56-470D-B3D3-016E55F65CC3

Q35649141-4C537E4D-CD7D-437D-B2F1-B4E5389EB574

Q35649141-50D60463-72DC-4899-BA45-A2878FC05924

Q35649141-51D3770C-8541-4943-AC97-3F80786D53AA

P304

Q35649141-6B69493D-BF52-4D4B-8923-4BC7E3BCCABE

P31

Q35649141-D14CE020-14DB-4878-B961-5432F2280AC4

P356

Q35649141-589DB6F5-8101-401B-845A-3CB6DB6CD55D

P433

Q35649141-44707CF5-9ADF-41D5-9035-A406F32A7A26

P478

Q35649141-8F397186-ECC6-42D0-8EDF-B1026F6D80B5

P577

Q35649141-D500ECB5-DB76-4C85-8B6F-A304ADC9FFDF

P5875

Q35649141-21A29D35-8261-45F8-9282-7E7073E11EB5

P698

Q35649141-7F7A0CDB-1B7F-492F-945C-503372EAFB68

P932

Q35649141-3CF8283E-76C6-412C-A76C-D3197FEDB108

P356

P1433

Arthritis Care and Research

P1476

Assessment of health-related q ...... with polyangiitis (Wegener's).

@en

P2093

Carol A Langford

http://www.w3.org/2001/XMLSchema#string

Carol A McAlear

http://www.w3.org/2001/XMLSchema#string

David Cuthbertson

http://www.w3.org/2001/XMLSchema#string

E William St Clair

http://www.w3.org/2001/XMLSchema#string

Gary S Hoffman

http://www.w3.org/2001/XMLSchema#string

Gunnar Tomasson

http://www.w3.org/2001/XMLSchema#string

John C Davis

http://www.w3.org/2001/XMLSchema#string

John H Stone

http://www.w3.org/2001/XMLSchema#string

Maarten Boers

http://www.w3.org/2001/XMLSchema#string

Michael LaValley

http://www.w3.org/2001/XMLSchema#string

P2860

The MOS 36-ltem Short-Form Health Survey (SF-36)

Health-related quality of life in primary Sjögren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36.

Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).

Patient-reported outcome assessment in vasculitis may provide important data and a unique perspective

Health-related quality of life for patients with vasculitis and their spouses.

Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis.

Etanercept plus standard therapy for Wegener's granulomatosis.

Design of the Wegener's Granulomatosis Etanercept Trial (WGET).

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.

Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

P304

273-279

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ACR.20649

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51677090

http://www.w3.org/2001/XMLSchema#string

P698

21954229

http://www.w3.org/2001/XMLSchema#string

P932

3250569

http://www.w3.org/2001/XMLSchema#string